• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质子-核相互作用截面数据预测质子治疗中质子诱发 PET 图像的可靠性。

The reliability of proton-nuclear interaction cross-section data to predict proton-induced PET images in proton therapy.

机构信息

Department of Radiation Oncology, Massachusetts General Hospital, Boston, 02114 MA, USA.

出版信息

Phys Med Biol. 2011 May 7;56(9):2687-98. doi: 10.1088/0031-9155/56/9/003. Epub 2011 Apr 5.

DOI:10.1088/0031-9155/56/9/003
PMID:21464534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3124369/
Abstract

In vivo PET range verification relies on the comparison of measured and simulated activity distributions. The accuracy of the simulated distribution depends on the accuracy of the Monte Carlo code, which is in turn dependent on the accuracy of the available cross-section data for β(+) isotope production. We have explored different cross-section data available in the literature for the main reaction channels ((16)O(p,pn)(15)O, (12)C(p,pn)(11)C and (16)O(p,3p3n)(11)C) contributing to the production of β(+) isotopes by proton beams in patients. Available experimental and theoretical values were implemented in the simulation and compared with measured PET images obtained with a high-resolution PET scanner. Each reaction channel was studied independently. A phantom with three different materials was built, two of them with high carbon or oxygen concentration and a third one with average soft tissue composition. Monoenergetic and SOBP field irradiations of the phantom were accomplished and measured PET images were compared with simulation results. Different cross-section values for the tissue-equivalent material lead to range differences below 1 mm when a 5 min scan time was employed and close to 5 mm differences for a 30 min scan time with 15 min delay between irradiation and scan (a typical off-line protocol). The results presented here emphasize the need of more accurate measurement of the cross-section values of the reaction channels contributing to the production of PET isotopes by proton beams before this in vivo range verification method can achieve mm accuracy.

摘要

体内 PET 范围验证依赖于测量和模拟的活性分布的比较。模拟分布的准确性取决于蒙特卡罗代码的准确性,而蒙特卡罗代码的准确性又取决于用于 β(+)同位素产生的可用截面数据的准确性。我们已经探索了文献中用于质子束在患者中产生 β(+)同位素的主要反应通道((16)O(p,pn)(15)O、(12)C(p,pn)(11)C 和 (16)O(p,3p3n)(11)C)的不同可用截面数据。将可用的实验和理论值实施到模拟中,并将其与使用高分辨率 PET 扫描仪获得的测量 PET 图像进行比较。每个反应通道都进行了独立研究。构建了一个具有三种不同材料的体模,其中两种具有高碳或氧浓度,第三种具有平均软组织组成。对体模进行单能和 SOBP 场照射,并将测量的 PET 图像与模拟结果进行比较。当使用 5 分钟扫描时间时,组织等效材料的不同截面值会导致射程差异小于 1 毫米,而在使用 30 分钟扫描时间和 15 分钟照射与扫描之间的延迟(典型的离线协议)时,差异接近 5 毫米。这里呈现的结果强调了在体内范围验证方法能够实现毫米精度之前,需要更准确地测量质子束产生 PET 同位素的反应通道的截面值。

相似文献

1
The reliability of proton-nuclear interaction cross-section data to predict proton-induced PET images in proton therapy.质子-核相互作用截面数据预测质子治疗中质子诱发 PET 图像的可靠性。
Phys Med Biol. 2011 May 7;56(9):2687-98. doi: 10.1088/0031-9155/56/9/003. Epub 2011 Apr 5.
2
Determination of elemental tissue composition following proton treatment using positron emission tomography.利用正电子发射断层扫描术测定质子治疗后的元素组织成分。
Phys Med Biol. 2013 Jun 7;58(11):3815-35. doi: 10.1088/0031-9155/58/11/3815. Epub 2013 May 16.
3
An experimental approach to improve the Monte Carlo modelling of offline PET/CT-imaging of positron emitters induced by scanned proton beams.一种提高扫描质子束诱发正电子发射断层扫描/计算机断层扫描成像的蒙特卡罗模拟的实验方法。
Phys Med Biol. 2013 Aug 7;58(15):5193-213. doi: 10.1088/0031-9155/58/15/5193. Epub 2013 Jul 9.
4
Feasibility study of using fall-off gradients of early and late PET scans for proton range verification.使用早期和晚期 PET 扫描的下降梯度进行质子射程验证的可行性研究。
Med Phys. 2017 May;44(5):1734-1746. doi: 10.1002/mp.12191. Epub 2017 Mar 30.
5
The impact of uncertainties in the CT conversion algorithm when predicting proton beam ranges in patients from dose and PET-activity distributions.当根据剂量和 PET 活性分布预测质子束在患者中的射程时,CT 转换算法中的不确定性的影响。
Phys Med Biol. 2010 Dec 21;55(24):7557-71. doi: 10.1088/0031-9155/55/24/011. Epub 2010 Nov 19.
6
Measurement of theC(p,n)N reaction cross section below 150 MeV.测量低于 150 兆电子伏的 C(p,n)N 反应截面。
Phys Med Biol. 2024 Mar 26;69(7). doi: 10.1088/1361-6560/ad2b97.
7
Patient CT-based simulation study of secondary-electron-bremsstrahlung imaging for range verification in proton therapy: comparison with prompt gamma and PET imaging for simplified proton pencil beam and SOBP irradiation scenarios.基于患者CT的二次电子轫致辐射成像在质子治疗射程验证中的模拟研究:与简化质子笔形束和扩展野照射方案下的即时伽马成像及PET成像的比较
Phys Med Biol. 2025 May 22;70(11). doi: 10.1088/1361-6560/add4b7.
8
Clinical CT-based calculations of dose and positron emitter distributions in proton therapy using the FLUKA Monte Carlo code.使用FLUKA蒙特卡罗代码基于临床CT进行质子治疗中剂量和正电子发射体分布的计算。
Phys Med Biol. 2007 Jun 21;52(12):3369-87. doi: 10.1088/0031-9155/52/12/004. Epub 2007 May 17.
9
GPU accelerated Monte Carlo scoring of positron emitting isotopes produced during proton therapy for PET verification.用于正电子发射同位素的 GPU 加速蒙特卡罗评分质子治疗的 PET 验证期间产生。
Phys Med Biol. 2022 Dec 12;67(24). doi: 10.1088/1361-6560/aca515.
10
Clinical application of in-room positron emission tomography for in vivo treatment monitoring in proton radiation therapy.用于质子放射治疗中体内治疗监测的室内正电子发射断层扫描的临床应用。
Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):183-9. doi: 10.1016/j.ijrobp.2012.12.010. Epub 2013 Feb 4.

引用本文的文献

1
Zinc-Doped Iron Oxide Nanoparticles as a Proton-Activatable Agent for Dose Range Verification in Proton Therapy.锌掺杂氧化铁纳米颗粒作为质子治疗中剂量范围验证的质子激活剂。
Molecules. 2023 Sep 29;28(19):6874. doi: 10.3390/molecules28196874.
2
In vivo production of fluorine-18 in a chicken egg tumor model of breast cancer for proton therapy range verification.在乳腺癌鸡胚肿瘤模型中进行体内氟-18 的生产,用于质子治疗范围验证。
Sci Rep. 2022 Apr 30;12(1):7075. doi: 10.1038/s41598-022-11037-7.
3
Proton range monitoring using 13N peak for proton therapy applications.

本文引用的文献

1
The impact of uncertainties in the CT conversion algorithm when predicting proton beam ranges in patients from dose and PET-activity distributions.当根据剂量和 PET 活性分布预测质子束在患者中的射程时,CT 转换算法中的不确定性的影响。
Phys Med Biol. 2010 Dec 21;55(24):7557-71. doi: 10.1088/0031-9155/55/24/011. Epub 2010 Nov 19.
2
Systematic analysis of biological and physical limitations of proton beam range verification with offline PET/CT scans.使用离线PET/CT扫描对质子束射程验证的生物学和物理限制进行系统分析。
Phys Med Biol. 2009 Jul 21;54(14):4477-95. doi: 10.1088/0031-9155/54/14/008. Epub 2009 Jun 26.
3
利用 13N 峰进行质子治疗应用中的质子射程监测。
PLoS One. 2022 Feb 15;17(2):e0263521. doi: 10.1371/journal.pone.0263521. eCollection 2022.
4
Measurement of nuclear reaction cross sections by using Cherenkov radiation toward high-precision proton therapy.利用切伦科夫辐射测量核反应截面以实现高精度质子治疗。
Sci Rep. 2018 Feb 7;8(1):2570. doi: 10.1038/s41598-018-20906-z.
5
Feasibility study of using fall-off gradients of early and late PET scans for proton range verification.使用早期和晚期 PET 扫描的下降梯度进行质子射程验证的可行性研究。
Med Phys. 2017 May;44(5):1734-1746. doi: 10.1002/mp.12191. Epub 2017 Mar 30.
6
Range Verification Methods in Particle Therapy: Underlying Physics and Monte Carlo Modeling.粒子治疗中的射程验证方法:基础物理与蒙特卡洛建模
Front Oncol. 2015 Jul 7;5:150. doi: 10.3389/fonc.2015.00150. eCollection 2015.
7
Monitoring proton therapy with PET.利用正电子发射断层显像(PET)监测质子治疗。
Br J Radiol. 2015 Jul;88(1051):20150173. doi: 10.1259/bjr.20150173. Epub 2015 May 20.
8
Mapping (15)O production rate for proton therapy verification.用于质子治疗验证的(15)O生成率映射
Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):453-9. doi: 10.1016/j.ijrobp.2015.01.023. Epub 2015 Mar 25.
9
Automation and uncertainty analysis of a method for in-vivo range verification in particle therapy.粒子治疗中体内射程验证方法的自动化与不确定性分析
Phys Med Biol. 2014 Oct 7;59(19):5903-19. doi: 10.1088/0031-9155/59/19/5903. Epub 2014 Sep 11.
10
Feasibility of Using Distal Endpoints for In-room PET Range Verification of Proton Therapy.使用远端端点进行质子治疗室内PET射程验证的可行性
IEEE Trans Nucl Sci. 2013 Oct;60(5):3290-3297. doi: 10.1109/NSSMIC.2012.6551892.
Clinical implementation of full Monte Carlo dose calculation in proton beam therapy.
质子束治疗中全蒙特卡罗剂量计算的临床应用
Phys Med Biol. 2008 Sep 7;53(17):4825-53. doi: 10.1088/0031-9155/53/17/023. Epub 2008 Aug 13.
4
Quantitative assessment of the physical potential of proton beam range verification with PET/CT.利用正电子发射断层显像/计算机断层扫描(PET/CT)对质子束射程验证的物理潜力进行定量评估。
Phys Med Biol. 2008 Aug 7;53(15):4137-51. doi: 10.1088/0031-9155/53/15/009. Epub 2008 Jul 17.
5
A potential method for in vivo range verification in proton therapy treatment.一种用于质子治疗中体内射程验证的潜在方法。
Phys Med Biol. 2008 Mar 7;53(5):1413-24. doi: 10.1088/0031-9155/53/5/016. Epub 2008 Feb 19.
6
Clinical CT-based calculations of dose and positron emitter distributions in proton therapy using the FLUKA Monte Carlo code.使用FLUKA蒙特卡罗代码基于临床CT进行质子治疗中剂量和正电子发射体分布的计算。
Phys Med Biol. 2007 Jun 21;52(12):3369-87. doi: 10.1088/0031-9155/52/12/004. Epub 2007 May 17.
7
Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy.质子治疗后使用正电子发射断层扫描和计算机断层扫描成像对束流传输和射程进行体内验证的患者研究。
Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):920-34. doi: 10.1016/j.ijrobp.2007.01.063.
8
PET/CT imaging for treatment verification after proton therapy: a study with plastic phantoms and metallic implants.质子治疗后用于治疗验证的PET/CT成像:一项使用塑料模体和金属植入物的研究
Med Phys. 2007 Feb;34(2):419-35. doi: 10.1118/1.2401042.
9
A filtering approach based on Gaussian-powerlaw convolutions for local PET verification of proton radiotherapy.一种基于高斯-幂律卷积的滤波方法用于质子放疗的局部正电子发射断层扫描(PET)验证
Phys Med Biol. 2006 Apr 21;51(8):1991-2009. doi: 10.1088/0031-9155/51/8/003. Epub 2006 Mar 30.
10
The modelling of positron emitter production and PET imaging during carbon ion therapy.碳离子治疗期间正电子发射体产生及PET成像的建模
Phys Med Biol. 2004 Dec 7;49(23):5217-32. doi: 10.1088/0031-9155/49/23/002.